Dermatitis, Atopic
Information
- Disease name
- Dermatitis, Atopic
- Disease ID
- Description
Disease area statistics
Chromosome band
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04599946 | Active, not recruiting | N/A | Goat Infant Formula Feeding and Eczema (the GIraFFE Study) | January 8, 2021 | September 2028 |
| NCT03428646 | Active, not recruiting | Study of Patients Receiving DUPIXENT® for Atopic Dermatitis (AD) | April 6, 2018 | March 30, 2027 | |
| NCT03422822 | Active, not recruiting | Phase 3 | Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis | March 8, 2018 | January 31, 2026 |
| NCT00152464 | Completed | Phase 3 | Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM) | March 20, 2002 | March 15, 2006 |
| NCT00159523 | Completed | N/A | Impact in Off-spring of Mothers After Perinatal Daily Intake of a Probiotic | December 2003 | September 2007 |
| NCT00185510 | Completed | Phase 4 | Efficacy and Safety Study of Advantan for Maintenance Treatment of Atopic Dermatitis | March 2005 | June 2006 |
| NCT00189917 | Completed | Phase 1 | Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in Patients With Atopic Disorders | April 2004 | |
| NCT00226057 | Completed | Phase 1 | Efalizumab for Moderate to Severe Atopic Dermatitis | June 2005 | May 2006 |
| NCT00257569 | Completed | Phase 3 | Study Of Atopic Dermatitis In Pediatrics | August 2005 | |
| NCT00267826 | Completed | N/A | Immunopharmacological Effects of Rituximab in Atopic Dermatitis | December 2005 | December 2006 |
| NCT00277433 | Completed | Histamine Pharmacogenetics in Children With Atopic Dermatitis | June 2004 | December 2009 | |
| NCT00354510 | Completed | Phase 2 | Topical GW842470X In Adults Patients With Moderate Atopic Dermatitis | March 2006 | |
| NCT00356642 | Completed | Phase 1 | Study Of Single And Ten Day Repeat Atopical Applications Of GW842470X Cream On The Skin Of Patients With Atopic Dermatitis | June 10, 2005 | December 21, 2005 |
| NCT00459576 | Completed | Risk of Asthma in Infants With Atopic Dermatitis | May 2005 | December 2012 | |
| NCT00480610 | Completed | Phase 3 | Treatment and Control of Atopic Dermatitis With 0.1% Tacrolimus Ointment | April 2004 | November 2005 |
| NCT00480896 | Completed | Phase 3 | Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointment | June 2004 | November 2005 |
| NCT00523952 | Completed | Phase 3 | Clinical Trial to Assess the Efficacy and Safety of Tacrolimus Ointment Treatment of Atopic Dermatitis in Adult Patients | January 2004 | September 2005 |
| NCT00534508 | Completed | Phase 2 | Distribution of Tacrolimus in Skin, Atopic Dermatitis | December 2000 | July 2001 |
| NCT00535691 | Completed | Phase 2 | Tacrolimus Ointment Pharmacokinetics in Infants With Atopic Dermatitis | April 2003 | December 2004 |
| NCT00541255 | Completed | A Long-Term Examination of Asthma From Childhood Through Adolescence | September 2007 | February 18, 2015 | |
| NCT00560326 | Completed | Phase 2 | Tacrolimus Ointment Long Term Safety in Young Children With Atopic Dermatitis | June 2003 | December 2006 |
| NCT00560378 | Completed | Phase 3 | Long-term Safety of Protopic in Atopic Eczema | June 1998 | June 2005 |
| NCT00616096 | Completed | N/A | Study of Immunoadsorption to Treat Severe Atopical Dermatitis Associated With Excessively High Serum IgE Levels | January 2008 | December 2009 |
| NCT00666159 | Completed | Phase 4 | Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Treating Pediatric Patients With Atopic Dermatitis | December 2002 | May 2003 |
| NCT00666302 | Completed | Phase 4 | A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic Dermatitis | October 2002 | November 2003 |
| NCT00667160 | Completed | Phase 4 | Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Pediatric Patients With Mild Atopic Dermatitis | December 2002 | November 2003 |
| NCT00673725 | Completed | Phase 4 | Locobase® REPAIR Used as an Adjunctive to Standard Therapy in Children With Moderate to Severe Atopic Dermatitis | March 2008 | September 2008 |
| NCT00689832 | Completed | Phase 4 | Protopic Ointment in Children Atopic Eczema | February 2004 | August 2005 |
| NCT00690105 | Completed | Phase 4 | Protopic Ointment in Adult Atopic Eczema of the Face | February 2004 | July 2005 |
| NCT00691145 | Completed | Phase 3 | Study to Evaluate the Efficacy and Safety of 0.1% and 0.03% Tacrolimus Ointment Administered in Adults With Moderate to Severe Atopic Dermatitis | October 2002 | February 2005 |
| NCT00691262 | Completed | Phase 3 | Study to Evaluate the Response to Treatment and Safety of 0.03% Tacrolimus (FK506) Ointment Administered in Pediatric Patients With Moderate to Severe Atopic Dermatitis | October 2003 | February 2005 |
| NCT00817076 | Completed | Phase 3 | Study of the Effectiveness and Safety of Desloratadine (Aerius) Syrup in Children With Allergic Skin Inflammation (P03475) | March 2003 | July 2003 |
| NCT00837551 | Completed | Phase 1/Phase 2 | Phase IIa Study of WBI-1001 Cream for Atopic Dermatitis | March 2008 | October 2008 |
| NCT00846235 | Completed | Phase 4 | Effect of Moisturising Creams on Skin Moisture in Atopic Dermatitis | December 2008 | May 2009 |
| NCT01063218 | Completed | Phase 4 | Evaluation of Cetaphil Advanced Usage to Control Light to Moderate Atopic Dermatitis, in Attempt to Reduce the Necessity of Topic Corticoids Application | December 2009 | October 2010 |
| NCT01098734 | Completed | Phase 2 | Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 Cream | November 2009 | November 2010 |
| NCT01299610 | Completed | Phase 2 | A Study to Test the Effect of 2 Different Doses of Topical GW870086X on Atopic Dermatitis Also Including a Postive Control and a Placebo | December 1, 2010 | April 14, 2011 |
| NCT01301508 | Completed | Phase 2 | Efficacy and Safety of AN2898 and AN2728 Topical Ointments to Treat Mild-to-Moderate Atopic Dermatitis | May 2011 | November 11, 2011 |
| NCT01326520 | Completed | N/A | Effect of Dietary Phospholipids on Atopic Dermatitis | March 2011 | October 2011 |
| NCT01381445 | Completed | Phase 1 | A Study Assessing GW870086's Potential to Cause Skin Thinning | April 14, 2011 | July 7, 2011 |
| NCT00106496 | Completed | Phase 4 | A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic Dermatitis | October 2004 | July 2006 |
| NCT00121381 | Completed | Phase 4 | Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis | May 2005 | January 2007 |
| NCT00146003 | Completed | Phase 2 | Efalizumab for Eczema | March 2005 | December 2007 |
| NCT03054428 | Completed | Phase 3 | Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis | March 21, 2017 | June 5, 2018 |
| NCT03059693 | Completed | Phase 1/Phase 2 | Efficacy and Tolerability of HAT1 in Patients With Moderate to Severe Atopic Dermatitis | February 29, 2016 | July 24, 2016 |
| NCT03085303 | Completed | N/A | Treatment of Atopic Dermatitis by a Full-Body Blue Light Device | March 16, 2017 | July 31, 2018 |
| NCT03096223 | Completed | Phase 1 | A Phase 1 Study of KHK4083 in Subjects With Atopic Dermatitis | April 10, 2017 | February 7, 2018 |
| NCT03139981 | Completed | Phase 1 | A Study To Evaluate ASN002 In Subjects With Atopic Dermatitis | April 12, 2017 | December 5, 2017 |
| NCT03233529 | Completed | Phase 2 | Crisaborole Ointment 2% Skin Biomarker Biopsy Study in Atopic Dermatitis | July 31, 2017 | May 4, 2018 |
| NCT03252730 | Completed | N/A | In-Use Test With a Cosmetic Product | January 30, 2017 | February 27, 2017 |
| NCT03345914 | Completed | Phase 3 | Study to Investigate the Efficacy and Safety of Dupilumab Administered With Topical Corticosteroids (TCS) in Participants ≥6 to <12 Years With Severe Atopic Dermatitis (AD) | November 17, 2017 | September 10, 2019 |
| NCT03346434 | Completed | Phase 2/Phase 3 | Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to <6 Years With Moderate-to-Severe Atopic Dermatitis (Liberty AD PRESCHOOL) | November 30, 2017 | July 8, 2021 |
| NCT03349060 | Completed | Phase 3 | Study to Evaluate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis | December 7, 2017 | March 26, 2019 |
| NCT03563066 | Completed | Phase 2 | Effect of Benralizumab in Atopic Dermatitis | September 4, 2018 | September 28, 2021 |
| NCT03568136 | Completed | Phase 2 | Investigation of Efficacy of Secukinumab in Patients With Moderate to Serve Atopic Dermatitis | September 18, 2018 | May 4, 2020 |
| NCT03575871 | Completed | Phase 3 | Study Evaluating Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis | June 29, 2018 | August 13, 2019 |
| NCT03627767 | Completed | Phase 3 | Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects | June 11, 2018 | October 7, 2020 |
| NCT03634345 | Completed | Phase 1 | Drug Drug Interaction Study Evaluating the Effect of Fluvoxamine or Fluconazole on PK and Safety of PF-04965842. | September 12, 2018 | December 13, 2018 |
| NCT03663673 | Completed | Phase 1 | Effect of Different Skin Creams on TEWL | September 1, 2018 | July 18, 2019 |
| NCT03672383 | Completed | N/A | Functional Study to Investigate the Efficacy of a New Medical Device (Modified Diprobase Formulation) | September 17, 2018 | October 17, 2018 |
| NCT03720470 | Completed | Phase 3 | Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy | October 29, 2018 | March 6, 2020 |
| NCT03722706 | Completed | N/A | Improving Therapeutic Patient Education for Atopic Dermatitis: Evaluation of a Parent Handbook | February 26, 2019 | March 30, 2020 |
| NCT03750643 | Completed | Phase 1 | A Study of LY3454738 in Healthy Participants and Participants With Atopic Dermatitis | November 29, 2018 | September 7, 2021 |
| NCT03754309 | Completed | Phase 2 | A Study of KY1005 in Patients With Moderate to Severe Atopic Dermatitis | December 13, 2018 | October 8, 2020 |
| NCT03798561 | Completed | Phase 1 | Study to Evaluate ASN008 Topical Gel (TG) | January 14, 2019 | March 20, 2020 |
| NCT03822832 | Completed | Phase 2 | A Study in Patients With Atopic Eczema to Test How Effective BI 655130 is and How Well it is Tolerated | February 12, 2019 | July 22, 2020 |
| NCT03868098 | Completed | Phase 4 | Different Application Rates of Crisaborole Ointment 2% in Adults With Mild to Moderate Atopic Dermatitis | May 21, 2019 | November 25, 2020 |
| NCT03901144 | Completed | Phase 2 | A NOVel Moisturiser for Atopic Dermatitis: Effect on the Skin Barrier | February 21, 2019 | December 10, 2019 |
| NCT04065633 | Completed | Phase 1 | Study of Commercial and Phase 3 of PF-04965842 Formulations, Estimation of Effect of Food on Commercial Formulation | July 18, 2019 | December 14, 2019 |
| NCT04081350 | Completed | Phase 1 | A Study of LY3471851 in Participants With Eczema | December 4, 2019 | June 24, 2022 |
| NCT04179760 | Completed | Phase 1/Phase 2 | Safety and Efficacy of SCM-AGH in Subjects With Moderate to Severe Atopic Dermatitis | March 24, 2020 | October 26, 2022 |
| NCT04365387 | Completed | Phase 2 | A Study to Assess Immunization Responses in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Treated With Nemolizumab | March 5, 2020 | July 7, 2023 |
| NCT04440410 | Completed | Evaluation of Cutaneous and Circulating Inflammatory Biomarkers in Hidradenitis Suppurativa and Atopic Dermatitis | May 28, 2020 | March 24, 2021 | |
| NCT04635072 | Completed | Early Phase 1 | Stabilized Whole Rice Bran (SWRB) for Mild to Moderate Atopic Dermatitis | September 21, 2020 | September 20, 2021 |
| NCT04740892 | Completed | N/A | A Study of a Moisturizing Cream and Baby Wash in the Management of Mild to Moderate Atopic Dermatitis in Infants, Toddlers and Children | January 21, 2021 | February 6, 2023 |
| NCT04760314 | Completed | Phase 3 | A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic Dermatitis | March 10, 2021 | February 1, 2023 |
| NCT04800315 | Completed | Phase 2 | A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic Dermatitis | May 14, 2021 | November 9, 2022 |
| NCT04975438 | Completed | Phase 1 | Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis | November 18, 2021 | March 13, 2023 |
| NCT05014438 | Completed | Phase 2 | A Study of BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic Dermatitis | August 17, 2021 | August 22, 2022 |
| NCT05094700 | Completed | N/A | A Study of a Polymeric Surfactant Technology Cleanser in Sensitive Skin Participants | October 25, 2021 | November 30, 2021 |
| NCT05149313 | Completed | Phase 3 | A Study of Lebrikizumab in Combination With Topical Corticosteroids in Participants Having Atopic Dermatitis (AD) That Are Not Adequately Controlled or Non-eligible for Cyclosporine | December 23, 2021 | May 7, 2024 |
| NCT05226143 | Completed | N/A | A Study of an Eczema Spot Treatment in Providing Eczema Symptoms Relief and Lasting Itch Relief to Affected Skin Area | February 21, 2022 | March 9, 2022 |
| NCT05450198 | Completed | Phase 1 | Multiple Rising Dose Study of MK-6194 in Participants With Atopic Dermatitis (MK-6194-008) | August 8, 2022 | May 22, 2024 |
| NCT05544591 | Completed | Phase 2 | Evaluation of 611 in Chinese Adults With Moderate to Severe Atopic Dermatitis | October 26, 2022 | September 20, 2023 |
| NCT05590338 | Completed | Phase 1 | A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic of GSK1070806 After a Single Intravenous Dose in Healthy Male and Female Caucasian, Chinese and Japanese Participants Aged 18 to 65 Years of Age Inclusive | November 4, 2022 | February 7, 2024 |
| NCT05641558 | Completed | Phase 1/Phase 2 | Evaluation of 611 in Chinese Adult Patients With Moderate-to-Severe Atopic Dermatitis | October 18, 2021 | October 21, 2022 |
| NCT05870865 | Completed | Phase 2 | A Study to Evaluate the Anti-pruritic Effectiveness of ASN008 in Adults With Mild to Moderate Atopic Dermatitis | May 3, 2023 | December 28, 2023 |
| NCT01602341 | Completed | Phase 2 | Efficacy and Safety of AN2728 Topical Ointment to Treat Adolescents With Atopic Dermatitis | August 2012 | January 2013 |
| NCT01652885 | Completed | Phase 1/Phase 2 | Safety, Tolerability, and PK of AN2728 in Adolescents With Atopic Dermatitis | July 2012 | November 2012 |
| NCT01673529 | Completed | Phase 1 | Investigation of Topical SB705498 on Healthy Volunteers | July 17, 2012 | October 4, 2012 |
| NCT01737710 | Completed | N/A | Atopic Dermatitis Research Network (ADRN) Influenza Vaccine Study | October 2012 | May 2013 |
| NCT01782729 | Completed | Phase 4 | An Efficacy and Safety Study of Tacrolimus Ointment in Pediatric Participants With Atopic Dermatitis | March 2008 | November 2008 |
| NCT01828879 | Completed | Phase 4 | An Efficacy and Safety Study of Tacrolimus Ointment in Adult Participants With Atopic Dermatitis | November 2007 | December 2009 |
| NCT01920464 | Completed | Place of Flixovate® in the Treatment Pathway and Its Conditions of Use in Infants Aged From 3 to 12 Months Between 2010 and 2012 by French GPs and Private Paediatricians | April 2013 | October 2013 | |
| NCT01945086 | Completed | Phase 2 | A Study of Ustekinumab (STELARA®) in Adult Japanese Participants With Severe Atopic Dermatitis | September 2013 | December 2014 |
| NCT01948869 | Completed | N/A | Efficacy/Safety Study to Explore a New Revised Topical Formulation in Atopic Dermatitis | October 2013 | June 2014 |
| NCT02001181 | Completed | Phase 2 | Tofacitinib Ointment For Atopic Dermatitis (Atopic Eczema) | December 2013 | September 2014 |
| NCT02028546 | Completed | N/A | The Effect of Bathing and Moisturizers on Skin Hydration in Atopic Dermatitis: an in Vivo Study | January 2013 | April 2013 |
| NCT02115399 | Completed | ADRN Barrier/Immunoprofiling Exploratory Pilot Study | April 2014 | June 2015 | |
| NCT02118766 | Completed | Phase 3 | Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis | March 2014 | April 2015 |
| NCT02118792 | Completed | Phase 3 | Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Aged 2 Years and Older) With Atopic Dermatitis | March 2014 | April 2015 |
| NCT02182557 | Completed | Phase 3 | WAL 801 CL Dry Syrup in Paediatric Atopic Dermatitis Patients | June 2001 | |
| NCT02182570 | Completed | Phase 3 | WAL 801 CL Dry Syrup in Pediatric Atopic Dermatitis Patients | June 2001 | |
| NCT02277743 | Completed | Phase 3 | Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis | October 2014 | February 2016 |
| NCT02277769 | Completed | Phase 3 | Study of Dupilumab (REGN668/SAR231893) Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis | November 30, 2014 | January 31, 2016 |
| NCT02343783 | Completed | Early Phase 1 | A Study to Evaluate Use of Induced Skin Blisters in Adult Participants With Atopic Dermatitis, Allergic Asthma and Atopic Healthy Participants | January 2015 | September 2015 |
| NCT02343861 | Completed | N/A | The Effectiveness of Tailored Messages on the Usage of Emollient in Patients With Atopic Dermatitis | January 2015 | May 2015 |
| NCT02411162 | Completed | Phase 1 | A Single Dose Phase I Exploratory Study in Healthy Volunteers With GSK2894512 Cream | July 7, 2015 | September 24, 2015 |
| NCT02466152 | Completed | Phase 1 | Pharmacokinetic Study of Topical GSK2894512 Cream | May 28, 2015 | October 27, 2015 |
| NCT02534428 | Completed | N/A | Wool Clothing for the Management of Childhood Atopic Dermatitis | June 2014 | May 2015 |
| NCT02534467 | Completed | Phase 4 | Does Treatment With Montelukast Improve Symptoms of Atopic Dermatitis in Children? | July 9, 2015 | December 4, 2018 |
| NCT02564055 | Completed | Phase 2 | A Dose-Finding Study of GSK2894512 Cream in Subjects With Atopic Dermatitis (AD) | December 1, 2015 | January 12, 2017 |
| NCT02576093 | Completed | Phase 1 | Safety, Tolerability, Pharmacokinetics and Efficacy of WOL071-007 in Atopic Dermatitis Patients | March 2014 | July 2015 |
| NCT02585986 | Completed | N/A | Intervention Study to Evaluate a Probiotic in Mild Atopic Dermatitis Young Patients | January 2016 | August 2016 |
| NCT02590289 | Completed | Phase 1 | A Pharmacokinetic Study to Evaluate BBI-5000 Capsules and Food Effect in Healthy Adult Subjects | October 2015 | December 2015 |
| NCT02595008 | Completed | Phase 2 | Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Atopic Dermatitis | August 28, 2015 | August 25, 2017 |
| NCT02615561 | Completed | N/A | Curing Atopic Dermatits in Children With a Commerical Medical Device and Maintaining Healthy Skin by Using a New Cosmetic Product | December 15, 2015 | September 7, 2016 |
| NCT02627989 | Completed | An Observational Study Investigating the Treatment Satisfaction of Atopic Dermatitis Patients Who Have Switched to Ointment (W/O Emulsion) Formulation of Very Strong Class Topical Corticosteroids | December 10, 2015 | January 17, 2017 | |
| NCT02637206 | Completed | Phase 1 | Skin Irritation Study of GSK2894512 Cream | October 27, 2015 | December 2, 2015 |
| NCT02655679 | Completed | Phase 1/Phase 2 | An Ascending Multiple Dose Study of VTP-38543 in Adult Participants With Mild to Moderate Atopic Dermatitis | December 15, 2015 | September 9, 2016 |
| NCT02680301 | Completed | Phase 4 | Topical Steroid Formulation and Wet Wraps | March 2016 | June 1, 2018 |
| NCT02732314 | Completed | Phase 4 | Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitis | March 2016 | June 2016 |
| NCT02739009 | Completed | Phase 1 | First in Human of Single and Multiple Doses of MOR106 | April 2016 | August 1, 2017 |
| NCT02835170 | Completed | Phase 2/Phase 3 | Study of Autologous Total Immunoglobulin G Therapy for Atopic Dermatitis | April 2, 2015 | March 27, 2017 |
| NCT02866864 | Completed | Animal Allergy in Korean Veterinary Researcher | August 24, 2016 | September 1, 2016 | |
| NCT02900131 | Completed | Phase 2 | Efficacy, Safety and Dose Finding Trial of Topical Jaungo Application in Atopic Dermatitis Patients | September 19, 2016 | March 16, 2017 |
| NCT02906475 | Completed | N/A | Atopic Dermatitis in Atopy Predisposed Infants | November 2016 | December 2020 |
| NCT02910011 | Completed | Phase 2 | Topical NanoDox® for Atopic Dermatitis | May 18, 2017 | November 30, 2018 |
| NCT02916888 | Completed | A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists | September 2016 | December 2017 | |
| NCT04185584 | Enrolling by invitation | Long-Term Safety Follow-Up Study of SCM-AGH in Subjects Who Participated and Administered SCM-AGH in to Severe Atopic Dermatitis Clinical Trials | August 25, 2020 | March 31, 2025 | |
| NCT06353087 | Not yet recruiting | Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry) | April 1, 2024 | November 15, 2025 | |
| NCT06324812 | Not yet recruiting | Phase 1/Phase 2 | Evaluation of 611 in Chinese Children and Adolescents With Moderate to Severe Atopic Dermatitis | March 2024 | August 2024 |
| NCT06447506 | Not yet recruiting | Phase 2 | Long-Term Study (AtDvance) to Evaluate GSK1070806 in Atopic Dermatitis. | June 4, 2024 | November 7, 2029 |
| NCT05674695 | Recruiting | Spanish Academy of Dermatology and Venereology Registry of Atopic Dermatitis Therapy | January 1, 2019 | January 1, 2029 | |
| NCT05078294 | Recruiting | Results in Real Clinical Practice of Treatment of Moderate-severe Atopic Dermatitis | August 1, 2021 | November 1, 2024 | |
| NCT04684485 | Recruiting | Phase 2 | To Assess the Efficacy and Safety of SCD-044 in the Treatment of Moderate to Severe Atopic Dermatitis | July 30, 2021 | June 2025 |
| NCT04011215 | Recruiting | N/A | Wool Clothing for the Management of Childhood Atopic Dermatitis (DESSINE2) | September 23, 2019 | October 2024 |
| NCT05177744 | Recruiting | Toxicity of Micro and Nano Plastics Combined With Environmental Contaminants on the Risk of Allergic Disease | October 5, 2022 | February 28, 2025 | |
| NCT06094179 | Recruiting | Phase 1/Phase 2 | Evaluate the Safety, Tolerability of BAT6026 | November 9, 2023 | October 15, 2025 |
| NCT01631617 | Recruiting | Phase 2 | Effects of Treatments on Atopic Dermatitis | September 18, 2012 | January 1, 2025 |
| NCT05250115 | Recruiting | A Study to Learn About the Study Medicine (Called Abrocitinib) in Adult Patients With Moderate to Severe Atopic Dermatitis | May 10, 2022 | April 14, 2025 | |
| NCT05999799 | Recruiting | Phase 2 | A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis | November 16, 2023 | June 25, 2025 |
| NCT04878770 | Recruiting | N/A | NMF-CsA-Dupi Trial | August 16, 2021 | January 1, 2025 |
| NCT05391061 | Recruiting | A Study to Learn About the Study Medicine (Called Cibinqo) in People With Atopic Dermatitis | January 7, 2023 | November 22, 2027 | |
| NCT06173284 | Recruiting | Phase 3 | Evaluation of 611(Recombinant Humanized Anti-interleukin-4 Receptor Alpha IgG4 Monoclonal Antibody) in Chinese Adults With Moderate to Severe Atopic Dermatitis | January 22, 2024 | May 2026 |
| NCT05023668 | Recruiting | China Atopic Dermatitis Registry Study | July 28, 2021 | October 2024 | |
| NCT06248814 | Recruiting | Phase 1 | A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986326 in Participants With Atopic Dermatitis | March 21, 2024 | October 31, 2025 |
| NCT01497119 | Terminated | Phase 2 | A Study of JNJ-39758979 in Adult Japanese Patients With Moderate Atopic Dermatitis | October 2011 | February 2012 |
| NCT01772056 | Terminated | Phase 3 | Efficacy Study of Topical Twice Weekly Fluticasone Treatment to Reduce Relapse in Atopic Dermatitis in Children | December 2009 | March 2013 |
| NCT04086121 | Terminated | Phase 2 | A Study to Test the Long-term Safety of BI 655130 in Patients With Atopic Eczema Who Took Part in Study 1368-0032 | September 24, 2019 | February 23, 2022 |
| NCT03055195 | Terminated | Phase 2 | Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic Dermatitis | March 21, 2017 | December 6, 2017 |
| NCT04220411 | Terminated | Phase 1/Phase 2 | A Study for AR100DP1 in Mild to Moderate Atopic Dermatitis (AD) | December 8, 2020 | June 13, 2022 |
| NCT00671528 | Terminated | Phase 4 | Safety and Efficacy of Quadriderme® in the Treatment of Impetiginous Eczema (Study P05134AM4) | July 2009 | May 2010 |
| NCT02317276 | Terminated | Phase 4 | A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawal | December 2014 | April 6, 2017 |
| NCT05486208 | Terminated | Phase 1 | A Study of LY3844583 in Healthy Participants and Participants With Atopic Dermatitis | August 11, 2022 | January 20, 2024 |
| NCT04791319 | Terminated | Phase 2 | A Study of Bermekimab (JNJ-77474462) in the Treatment of Participants With Moderate to Severe Atopic Dermatitis | May 3, 2021 | March 31, 2022 |
| NCT02582788 | Terminated | N/A | Bathing Additives in Pediatric Atopic Dermatitis | October 2015 | April 2018 |
| NCT05639738 | Terminated | N/A | Assessment of Clinical, Biological and Biometrological Paramaters in Adult Subjects Suffering From AD | March 8, 2022 | June 15, 2022 |
| NCT04990440 | Terminated | Phase 2 | A Study of Bermekimab for the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis | September 2, 2021 | March 9, 2022 |
| NCT02634905 | Terminated | N/A | A Multicenter Randomized Control Trial in Children With Moderate to Severe Atopic Dermatitis to Assess the Benefit of a Nurse-led One-to-one Education Program in Addition to Standard Care Compared to Standard Care Alone on the Long Term Control of Disease Severity at 6 Months | February 2016 | March 2021 |
| NCT02713035 | Terminated | N/A | Behavioral Self-Help Intervention for Pediatric Atopic Dermatitis and Eczema Patients | March 2016 | July 2017 |
| NCT05004324 | Unknown status | Phase 3 | Safety and Efficacy of FURESTEM-AD Inj. for Moderate to Severe Atopic Dermatitis (AD) | June 29, 2021 | April 2023 |
| NCT03907228 | Unknown status | N/A | Study to Evaluate the Use of RHT-3201 in SCORAD Reduction in Young Patients With Atopic Dermatitis | March 15, 2019 | May 2020 |
| NCT03183440 | Unknown status | N/A | Efficacy Of Antenatal Maternal Supplementation With GOS/Inulin Prebiotics On Atopic Dermatitis Prevalence In High-Risk One-Year-Old Children | February 13, 2018 | August 2023 |
| NCT04938700 | Unknown status | Phase 4 | Study on the Correlation Between Intestinal Microecology and Allergic Diseases in Children | March 1, 2020 | December 1, 2023 |
| NCT03042624 | Unknown status | N/A | Efficacy of Fermented Rice Flour for the Treatment of Atopic Dermatitis: Randomized, Double-blind Controlled Trial | January 24, 2017 | May 31, 2017 |
| NCT04617977 | Unknown status | N/A | Integrative Body-Mind-Spirit Intervention for Families With Children Suffering From Eczema | August 23, 2021 | December 31, 2023 |
| NCT04761978 | Unknown status | Efficacy and Tolerance of JAK Inhibitors in ATU for Atopic Dermatitis | September 1, 2021 | September 2022 | |
| NCT01447381 | Unknown status | Systemic Therapies for Pediatric Atopic Dermatitis | October 2011 | July 2021 | |
| NCT01011621 | Unknown status | Phase 3 | Efficacy and Tolerability of Prednisolone Acetate 0.5% Cream Versus Betamethasone Valerate 0.1% Cream in Cortisosensitive Dermatosis | February 2010 | |
| NCT02286700 | Unknown status | Phase 3 | Skin Effects of a Topical Amino Acid Moisturizing Cream and Desonide in Atopic Dermatitis | November 2014 | March 2015 |
| NCT01691209 | Withdrawn | N/A | Efficacy/Safety Study to Explore a New Topical Formulation in Atopic Dermatitis | October 2013 | June 2014 |
| NCT03808532 | Withdrawn | Phase 2 | Moisturizer to Prevent Atopic Dermatitis | June 2020 | December 2022 |
- OMIM Phenotype Series Number (OMIM)
- PS603165
- MeSH unique ID (MeSH (Medical Subject Headings))
- D003876